1.Liver transplantation for primary biliary cirrhosis: retrospective analysis of 52 patients in QLTS.
Chong-En XU ; Stephen V LYNCH ; Glenda A BALDERSON ; Jonathan FAWCETT ; Russell W STRONG ; Shinn YEONG
Chinese Journal of Hepatology 2004;12(9):543-545
OBJECTIVERetrospectively analyzing post-transplant primary biliary cirrhosis patients to document the actual survival time, the cause of post-transplant death, and recurrences after liver transplantation in patients followed up by the Queensland Liver Transplant Service (QLTS).
METHODSThe case notes of all post-piggyback liver transplantation patients followed up by QLTS were reviewed. We analyzed the clinical characteristics of the PBC patients, post-transplant actual survival rates, the causes of post-transplant death, and risk factors of recurrence, and compared the survival rates between patients with and without liver transplantation using a European model.
RESULTSFifty-two post-transplant patients with 54 transplantations were identified with an average age of 53 years and a mean follow-up time of 55 months. The actual survival times of PBC patients with grafts for 1 years, 5 years and 10 years were 88.4%, 80.1%, 76.9% and 80.9%, 65.4%, 19.8%. The causes of death were MOF intra-abdominal bleeding, renal failure, sepsis and cardiovascular diseases. Comparing the survival rates between with and without transplantation, 8.5% of PBC patients have recurrences with an average recurrent time of 34 months.
CONCLUSION(1) Liver transplantation could improve survival rates, but the optimum time for transplantation should be focused on; (2) A long-term and larger follow-up sampling should be done to understand the effects of recurrences on patient's long-term survival; (3) CsA may play a more important role in preventing recurrence of PBC than Tacrolimus
Cyclosporine ; therapeutic use ; Female ; Follow-Up Studies ; Graft Rejection ; prevention & control ; Humans ; Liver Cirrhosis, Biliary ; surgery ; Liver Transplantation ; mortality ; Male ; Middle Aged ; Postoperative Period ; Retrospective Studies ; Secondary Prevention ; Survival Rate ; Treatment Outcome